Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box and leucine-rich repeat protein 21, pseudogene (FBXL21P) is a transcribed pseudogene related to the F-box protein family, which typically participate as substrate recognition subunits in SCF (SKP1–CUL1–F-box) E3 ubiquitin ligase complexes involved in protein ubiquitination. However, FBXL21P does not encode a functional protein; instead, it is a pseudogene, meaning it is a genomic sequence similar to a gene but generally regarded as non-functional in humans due to accumulated mutations or lack of expression. The protein product described for closely related functional genes in this family is involved in regulating circadian rhythms by targeting CRY proteins for ubiquitination, but those functions do not apply to FBXL21P in humans. No known drugs target this pseudogene, and it is not considered a therapeutic or biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box and leucine-rich repeat protein 21, pseudogene (FBXL21P).